Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Goldstein

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of General Microbiology|June 1, 1977
The mechanism of action of nitro-heterocyclic antimicrobial drugs. Primary target of 1-methyl-2-nitro-5-vinylimidazole is DNAB P Goldstein, E Nielsen, M Berti, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycinR L Patron, M W Climo, B P Goldstein, et al.
Journal of Chemotherapy (Florence, Italy)|January 26, 2006
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocolR N Jones, T R Fritsche, H S Sader, et al.
The Journal of Antibiotics|March 1, 1988
Structure and biological activity of lipiarmycin BB Cavalleri, A Arnone, E Di Modugno, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditisM W Climo, R L Patron, B P Goldstein, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A)B P Goldstein, M Berti, F Ripamonti, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1995
In vitro activity of MDL 62,879 against gram-positive bacteria and Bacteroides speciesA Bartoloni, A Mantella, B P Goldstein, et al.
Journal of Medicinal Chemistry|March 14, 1997
Semisynthetic derivatives of purpuromycin as potential topical agents for vaginal infectionsA Trani, C Dallanoce, G Panzone, et al.
Journal of Clinical Microbiology|May 28, 2010
In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trialM A Pfaller, R Hollis, B P Goldstein, et al.
Journal of Clinical Microbiology|August 1, 1994
Differential susceptibilities of enterococcal species to elfamycin antibioticsA Miele, B P Goldstein, M Bandera, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of General Microbiology|June 1, 1977
The mechanism of action of nitro-heterocyclic antimicrobial drugs. Primary target of 1-methyl-2-nitro-5-vinylimidazole is DNAB P Goldstein, E Nielsen, M Berti, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycinR L Patron, M W Climo, B P Goldstein, et al.
Journal of Chemotherapy (Florence, Italy)|January 26, 2006
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocolR N Jones, T R Fritsche, H S Sader, et al.
The Journal of Antibiotics|March 1, 1988
Structure and biological activity of lipiarmycin BB Cavalleri, A Arnone, E Di Modugno, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditisM W Climo, R L Patron, B P Goldstein, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A)B P Goldstein, M Berti, F Ripamonti, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1995
In vitro activity of MDL 62,879 against gram-positive bacteria and Bacteroides speciesA Bartoloni, A Mantella, B P Goldstein, et al.
Journal of Medicinal Chemistry|March 14, 1997
Semisynthetic derivatives of purpuromycin as potential topical agents for vaginal infectionsA Trani, C Dallanoce, G Panzone, et al.
Journal of Clinical Microbiology|May 28, 2010
In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trialM A Pfaller, R Hollis, B P Goldstein, et al.
Journal of Clinical Microbiology|August 1, 1994
Differential susceptibilities of enterococcal species to elfamycin antibioticsA Miele, B P Goldstein, M Bandera, et al.
Pageof 5